The Syrian Ibn Hayyan Company announced today, Thursday, the launch of a drug intended to treat patients of the emerging coronavirus, which causes the "Covid 19" disease.
The Syrian Radio "Sham FM" quoted the director of "Ibn Hayyan", the Syrian pharmaceutical industry, Dr. Rashid Al-Faisal, as statements announcing the price of the new drug and its availability in the markets.
According to Dr. Al-Faisal, the price of one package (30 tablets) of chloroquine, which is used in the therapeutic protocol for Corona virus that causes "Covid 19", is 6800 SP for citizens in Syria, or approximately $ 13 USD.
According to the radio, the drug is expected to be available in the market next week through the Syrian Ministry of Health.